期刊文献+

降压治疗的原则与趋势 被引量:3

Principles and Trends for Blood Pressure Controlling Therapy
暂未订购
导出
摘要 我国拥有庞大的高血压人群,高血压是导致心脑血管事件的重要危险因素之一。近年相继出现的大规模临床试验结果以及高血压指南使以往的高血压控制原则和用药方案得以更新。现将以循证医学证据和更新的高血压指南为依据,对降压治疗的原则和趋势进行综述,为临床合理、有效降压提供依据。 There are many patients with hypertension in our country. Hypertension is one of the most important risk factors leading to cardiovascular events. Recently, many clinical trials and guidelines on hypertension have renewed the principles of blood pressure control and drug choice in patients with hypertension. This article reviews the renewed principals and trends for blood pressure control through reasonable and effective strategies.
作者 谢瑞芹 崔炜
出处 《心血管病学进展》 CAS 2009年第4期572-574,共3页 Advances in Cardiovascular Diseases
关键词 高血压 降压治疗 原则 趋势 hypertension blood pressure control principle trend
  • 相关文献

参考文献15

  • 1Neal B,MacMahon S,Chapman N.Effects of ACE inhibitors,calcium antagonists,and other blood-pressure-lowering drugs:results of prospectively designed overviews of randomised trials.Blood Pressure Lowering Treatment Trialists'Collaboration[J].Lancet,2000,356(9246):1955-1964.
  • 2Rosendorff C,Black HR,Cannon CP,et al.Treatment of hypertension in the prevention and management of ischemic heart disease:a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention[J].Circulation,2007,115(21):2761-2788.
  • 3Mancia G,de Backer G,Dominiczak A,et al.2007 Guidelines for the management of arterial hypertension:The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension(ESH)and of the European Society of Cardiology(ESC)[J].Eur Heart J,2007,28(12):1462-1536.
  • 4Fox KM.Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease:randomised,double-blind,placebo-controlled,multicentre trial(the EUROPA study)[J].Lancet,2003,362(9386):782-788.
  • 5Nissen SE,Tuzcu EM,Libby P,et al.Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure:the CAMELOT study:a randomized controlled trial[J].JAMA,2004,292(18):2217-2225.
  • 6Umemura S.Significance of treating prehypertension with an angiotensin-receptor blocker-results from TROPHY study[J].Nippon Rinsho,2008,66(3):601-609.
  • 7van den Meiracker AH,van Montfrans GA.The most recent study into blood pressure lowering by amlodipine:the beginning of the end for the beta-blockers[J].Ned Tijdschr Geneeskd,2006,150(16):886-888.
  • 8Fujikawa K,Hasebe N,Kikuchi K.Cost-effectiveness analysis of hypertensiontreatment:controlled release nifedipine and candesartan low-dose combinationtherapy in patients with essential hypertension-the Nifedipine and CandesartanCombination(NICE-Combi)Study[J].Hypertens Res,2005,28(7):585-591.
  • 9Soucek M,Plachy M.The FEVER(Felodipine EVEnt Reduction)trial;a randomised,double-blind,placebo-controlled trial in Chinese hypertensive patients[J].Vnitr Lek,2007,53(1):63-70.
  • 10Bakris G,Hester A,Weber M,et al.The Diabetes Subgroup Baseline Characteristics of the Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension(ACCOMPLISH)Trial[J].J Cardiometab Syndr,2008,3(4):229-233.

同被引文献17

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部